Cargando…

Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine

BACKGROUND: Pyronaridine (PN) and chloroquine (CQ) are structurally related anti-malarial drugs with primarily the same mode of action. However, PN is effective against several multidrug-resistant lines of Plasmodium falciparum, including CQ resistant lines, suggestive of important operational diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kritsiriwuthinan, Kanyanan, Chaotheing, Sastra, Shaw, Philip J, Wongsombat, Chayaphat, Chavalitshewinkoon-Petmitr, Porntip, Kamchonwongpaisan, Sumalee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224238/ https://www.ncbi.nlm.nih.gov/pubmed/21849091 http://dx.doi.org/10.1186/1475-2875-10-242

Ejemplares similares

Plasmodium parasites mount an arrest response to dihydroartemisinin, as revealed by whole transcriptome shotgun sequencing (RNA-seq) and microarray study
por: Shaw, Philip J., et al.
Publicado: (2015)

Transcriptomic complexity of the human malaria parasite Plasmodium falciparum revealed by long-read sequencing
por: Shaw, Philip J., et al.
Publicado: (2022)

Identifying transcript 5′ capped ends in Plasmodium falciparum
por: Shaw, Philip J., et al.
Publicado: (2021)

Molecular characterization of Plasmodium falciparum uracil-DNA glycosylase and its potential as a new anti-malarial drug target
por: Suksangpleng, Thidarat, et al.
Publicado: (2014)

Inducible Knockdown of Plasmodium Gene Expression Using the glmS Ribozyme
por: Prommana, Parichat, et al.
Publicado: (2013)

Characterization of Plasmodium falciparum ATP-dependent DNA helicase RuvB3
por: Limudomporn, Paviga, et al.
Publicado: (2016)

Biochemical and functional characterization of Plasmodium falciparum DNA polymerase δ
por: Vasuvat, Jitlada, et al.
Publicado: (2016)

Inhibitory effects of anthracyclines on partially purified 5′–3′ DNA helicase of Plasmodium falciparum
por: Rattaprasert, Pongruj, et al.
Publicado: (2022)

Molecular characterization of Plasmodium falciparum DNA-3-methyladenine glycosylase
por: Pinthong, Nattapon, et al.
Publicado: (2020)

In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays
por: Kurth, Florian, et al.
Publicado: (2009)

Hybrid Inhibitors of Malarial Dihydrofolate Reductase with Dual Binding Modes That Can Forestall Resistance
por: Tarnchompoo, Bongkoch, et al.
Publicado: (2018)

Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection
por: Nagao, Yoshiro, et al.
Publicado: (2008)

Review of pyronaridine anti-malarial properties and product characteristics
por: Croft, Simon L, et al.
Publicado: (2012)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2019)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2022)

Development of Nested PCR-Heteroduplex Mobility Assay for Determination of Genetic Diversity in the Block 2 Region of the Plasmodium falciparum Merozoite Surface Protein 1 Gene
por: Kritsiriwuthinan, Kanyanan, et al.
Publicado: (2020)

Investigation of an Allosteric Deoxyhypusine Synthase Inhibitor in P. falciparum
por: Aroonsri, Aiyada, et al.
Publicado: (2022)

Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
por: Bukirwa, Hasifa, et al.
Publicado: (2014)

Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine
por: Pascual, Aurélie, et al.
Publicado: (2015)

Validation of Plasmodium falciparum deoxyhypusine synthase as an antimalarial target
por: Aroonsri, Aiyada, et al.
Publicado: (2019)

Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model
por: Tipsuwan, Wachiraporn, et al.
Publicado: (2011)

Efficacy and Safety of Pyronaridine–Artesunate for the Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax Malaria in Myanmar
por: Han, Kay Thwe, et al.
Publicado: (2020)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
por: Roth, Johanna M., et al.
Publicado: (2018)

Combining isothermal recombinase polymerase amplification with lateral flow assay for diagnosis of P. cynomolgi malaria infection
por: Rattaprasert, Pongruj, et al.
Publicado: (2023)

Monitoring drug resistance in Plasmodium falciparum clinical isolates collected from Northern Thailand
por: Uthaipibull, Chairat, et al.
Publicado: (2014)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening
por: Hoarau, Marie, et al.
Publicado: (2021)

Efficacy of indirect ELISA for serodiagnosis of melioidosis using immunodominant antigens from non-pathogenic Burkholderia thailandensis
por: Wajanarogana, Sumet, et al.
Publicado: (2016)

Genome-wide functional screening of drug-resistance genes in Plasmodium falciparum
por: Iwanaga, Shiroh, et al.
Publicado: (2022)

Distinct Allelic Diversity of Plasmodium vivax Merozoite Surface Protein 3-Alpha (PvMSP-3α) Gene in Thailand Using PCR-RFLP
por: Kritsiriwuthinan, Kanyanan, et al.
Publicado: (2023)

Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum
por: Kampoun, Tanyaluck, et al.
Publicado: (2023)

Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum
por: Pradines, Bruno, et al.
Publicado: (2010)

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
por: Monatrakul, Preeyaporn, et al.
Publicado: (2010)

Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?
por: Peatey, Christopher L, et al.
Publicado: (2012)

Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991–2019
por: Rathmes, Giulia, et al.
Publicado: (2020)

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice
por: SheelaNair, Arya, et al.
Publicado: (2022)

THE CULTIVATION OF MALARIAL PLASMODIA (PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM) IN VITRO
por: Bass, C. C., et al.
Publicado: (1912)

Inhibitory effect of novel iron chelator, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) and green tea extract on growth of Plasmodium falciparum
por: Thipubon, Phitsinee, et al.
Publicado: (2015)

Therapeutic efficacy of pyronaridine-artesunate (Pyramax(®)) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia
por: Alebachew, Mihreteab, et al.
Publicado: (2023)

Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children
por: Sowunmi, Akintunde, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mm7hosl53egahb6ushv84mtfho